NovaBay Pharmaceuticals, Inc. 5Y Revenue Growth (per Share)

5Y Revenue Growth (per Share) of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including 5Y Revenue Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 5Y Revenue Growth (per Share) for 2021 was 39.79% (a -10.58% decrease from previous year)
  • Annual 5Y Revenue Growth (per Share) for 2020 was 44.5% (a -45.89% decrease from previous year)
  • Annual 5Y Revenue Growth (per Share) for 2019 was 82.24% (a 31.39% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 5Y Revenue Growth (per Share) of NovaBay Pharmaceuticals, Inc.

Most recent 5Y Revenue Growth (per Share)of NBY including historical data for past 10 years.

Interactive Chart of 5Y Revenue Growth (per Share) of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. 5Y Revenue Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 39.79%
2020 44.5%
2019 82.24%
2018 62.59%
2017 47.83%
2016 -34.75%
2015 0.0%
2014 11.73%
2013 25.23%
2012 37.74%
2011 53.25%

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology